| 000 | 01759 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517123919.0 | ||
| 264 | 0 | _c20170804 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1557-8976 | ||
| 024 | 7 |
_a10.1089/vim.2016.0087 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCárdenas-Vargas, Albertina | |
| 245 | 0 | 0 |
_aEvaluation of the Immunogenicity of a Potyvirus-Like Particle as an Adjuvant of a Synthetic Peptide. _h[electronic resource] |
| 260 |
_bViral immunology _c12 2016 |
||
| 300 |
_a557-564 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCapsid Proteins _ximmunology |
| 650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemagglutinin Glycoproteins, Influenza Virus _xadministration & dosage |
| 650 | 0 | 4 | _aImmunogenicity, Vaccine |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPeptides _xadministration & dosage |
| 650 | 0 | 4 |
_aPotyvirus _ximmunology |
| 650 | 0 | 4 |
_aRecombinant Proteins _ximmunology |
| 650 | 0 | 4 | _aSpecific Pathogen-Free Organisms |
| 650 | 0 | 4 |
_aVaccines, Virus-Like Particle _ximmunology |
| 700 | 1 | _aElizondo-Quiroga, Darwin | |
| 700 | 1 | _aGutierrez-Ortega, Abel | |
| 700 | 1 | _aCharles-Niño, Claudia | |
| 700 | 1 | _aPedroza-Roldán, César | |
| 773 | 0 |
_tViral immunology _gvol. 29 _gno. 10 _gp. 557-564 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/vim.2016.0087 _zAvailable from publisher's website |
| 999 |
_c26595771 _d26595771 |
||